Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe Edwards

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Biology of the Cell|December 20, 2024
USP34 regulates endothelial PAR1 mRNA transcript expression and cellular signalingNorton Cheng, Monica Gonzalez Ramirez, Chloe Edwards, et al.
Journal of the American Academy of Dermatology|June 12, 2023
A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativaRebecca Jepsen, Chloe Edwards, Akshay Flora, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitorsJohn Porter, Andrew Payne, Ben de Candole, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Atropisomeric small molecule Bcl-2 ligands: determination of bioactive conformationJohn Porter, Andrew Payne, Ian Whitcombe, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|November 5, 2025
Temperature profiles in adult intensive care unit patients treated for infection in a tertiary intensive care unit: A single-centre prospective observational cohort studyBianca B Crichton, Allie Eathorne, Julieann Coombes, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 28, 2025
Sepsis in the absence of fever: Determining the criteria for and feasibility of future therapeutic temperature management trialsKyle C White, Kevin B Laupland, Manoj Saxena, et al.
Evidence-Based Mental Health|November 23, 2021
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depressionSheena Kristine Au-Yeung, James Griffiths, Sophie Roberts, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Biology of the Cell|December 20, 2024
USP34 regulates endothelial PAR1 mRNA transcript expression and cellular signalingNorton Cheng, Monica Gonzalez Ramirez, Chloe Edwards, et al.
Journal of the American Academy of Dermatology|June 12, 2023
A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativaRebecca Jepsen, Chloe Edwards, Akshay Flora, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitorsJohn Porter, Andrew Payne, Ben de Candole, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Atropisomeric small molecule Bcl-2 ligands: determination of bioactive conformationJohn Porter, Andrew Payne, Ian Whitcombe, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|November 5, 2025
Temperature profiles in adult intensive care unit patients treated for infection in a tertiary intensive care unit: A single-centre prospective observational cohort studyBianca B Crichton, Allie Eathorne, Julieann Coombes, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 28, 2025
Sepsis in the absence of fever: Determining the criteria for and feasibility of future therapeutic temperature management trialsKyle C White, Kevin B Laupland, Manoj Saxena, et al.
Evidence-Based Mental Health|November 23, 2021
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depressionSheena Kristine Au-Yeung, James Griffiths, Sophie Roberts, et al.
Pageof 1